FORM 8-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): January 7, 2021

Alpha-En Corporation

(Exact name of registrant as specified in its charter)

Delaware	001-12885	954622429
(State or Other Jurisdiction	(Commission	(I.R.S. Employer
of Incorporation)	File Number)	Identification No.)

28 Wells Ave, 2^nd Floor, Yonkers NY 10701

(Address of Principal Executive Offices) (Zip Code)

(914)418-2000

(Registrant’s telephone number, including area code)

N/A

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

[ ]	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

[ ]	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

[ ]	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

[ ]	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading Symbol(s)		Name of each exchange on which registered
Common Stock, par value $0.01 per share		ALPE		OTC

Item 5.02

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

The Board of Directors of alpha-Encorp on 1/6/2021 unanimously approved the nomination of Gary Goldman, MD to the Board of Directors. Dr. Goldman is a long term significant investor in the company through his family office and he brings a wealth of scientific knowledge and decades of investment experience to the company.

	Alpha-En Corporation

	By	/s/ Sam Pitroda
	Name:	Sam Pitroda
	Title:	Chairman and CEO

Date: 1/7/2021

INDEX TO EXHIBITS

Exhibit No.		Description